Sign Up to like & get
recommendations!
1
Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.4_suppl.610
Abstract: 610Background: Oxaliplatin is an essential drug in gastrointestinal oncology. Hypersensitivity reactions (HSR) occur frequently (incidence varying from 10% to 25%), leading to permanent treatment d...
read more here.
Keywords:
hypersensitivity reaction;
reaction single;
oxaliplatin desensitization;
desensitization hypersensitivity ... See more keywords